Universal BioPharma Research Inc.   Report issue

For profit Phase 2 Phase 3
Founded: Fresno CA United States (1998)

Organization Overview

First Clinical Trial
2011
NCT01336647
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

Universal Biopharma Reserach Inc.

Active Ingredients

Drugs in Phase 3 Trials (2)

traumeel (1 trial)

zeel (1 trial)

Drugs in Phase 2 Trials (1)

abametapir (Xeglyze) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Lice Infestations (Phase 2)

Osteoarthritis (Phase 3)

Osteoarthritis, Knee (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3